Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 75 of 250 entries
View as:
Phase: N/A
Priority: Normal
Start: 02/13/18
End: 08/13/18
Due: 08/13/19
Phase: N/A
Priority: Normal
Start: 06/30/15
End: 01/31/16
Due: 01/31/17
Phase: N/A
Priority: Normal
Start: 02/29/12
End: 05/31/13
Due: 05/31/14
Phase: N/A
Priority: Normal
Start: 12/20/24
End: 08/20/25
Due: 08/20/26
Phase: N/A
Priority: Normal
Start: 02/28/22
End: 03/15/24
Due: 03/15/25
Phase: N/A
Priority: Normal
Start: 01/01/18
End: 12/31/18
Due: 12/31/19
Phase: N/A
Priority: Normal
Start: 02/28/24
End: 08/28/24
Due: 08/28/25
Phase: N/A
Priority: Normal
Start: 02/28/22
End: 06/01/23
Due: 06/01/24
Phase: N/A
Priority: Normal
Start: 10/01/22
End: 03/30/23
Due: 03/30/24
Phase: N/A
Priority: Normal
Start: 12/31/16
End: 04/04/17
Due: 04/04/18
Phase: N/A
Priority: Normal
Start: 06/04/22
End: 08/01/22
Due: 08/01/23
Phase: N/A
Priority: Normal
Start: 07/15/22
End: 09/02/24
Due: 09/02/25
Phase: N/A
Priority: Normal
Start: 02/10/21
End: 06/25/21
Due: 06/25/22
Phase: N/A
Priority: Normal
Start: 06/01/25
End: 08/01/25
Due: 08/01/26
Phase: N/A
Priority: Normal
Start: 01/15/23
End: 08/01/24
Due: 08/01/25
Phase: N/A
Priority: Normal
Start: 11/30/21
End: 06/15/22
Due: 06/15/23
Phase: N/A
Priority: Normal
Start: 12/26/18
End: 07/16/20
Due: 07/16/21
Phase: N/A
Priority: Normal
Start: 06/15/20
End: 09/30/20
Due: 09/30/21
Phase: N/A
Priority: Normal
Start: 05/26/25
End: 07/15/25
Due: 07/15/26
Phase: N/A
Priority: Normal
Start: 02/15/19
End: 04/10/19
Due: 04/10/20
Phase: N/A
Priority: Normal
Start: 03/01/21
End: 11/01/21
Due: 11/01/22
Phase: N/A
Priority: Normal
Start: 09/03/21
End: 08/25/22
Due: 08/25/23
Phase: N/A
Priority: Normal
Start: 06/08/22
End: 12/20/23
Due: 12/20/24
Phase: N/A
Priority: Normal
Start: 03/20/24
End: 08/15/25
Due: 08/15/26
The Effects of Remifentanil on Attenuating the Hemodynamic Responses After Electroconvulsive Therapy
Phase: N/A
Priority: Normal
Start: 10/31/14
End: 12/31/14
Due: 12/31/15